Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

J E Fish; J P Karpel; T J Craig; G W Bensch; M Noonan; D R Webb; B Silverman; E J Schenkel; A R Rooklin; J W Ramsdell

doi:10.1067/mai.2000.110798

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

Identifier:nobleid.org/w1/20260515/45C01DFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/45C01DFC.svg?ark=w1%2F20260515%2F45C01DFC)](https://nobleid.org/work/w1/20260515/45C01DFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

Identifier:nobleid.org/w1/20260515/45C01DFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/45C01DFC.svg?ark=w1%2F20260515%2F45C01DFC)](https://nobleid.org/work/w1/20260515/45C01DFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work